Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Inventory Average (2011 - 2026)

Emergent BioSolutions (EBS) posted Inventory Average of $315.6 million for Q2 2026, down 5.93% on a QoQ basis from $335.5 million in Q1 2026, and down 3.28% year-over-year from $326.3 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Inventory Average (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported Inventory Average for 16 years, with the latest figure at $315.6 million in Q2 2026.

  • On a quarterly basis, Inventory Average fell 3.28% year-over-year to $315.6 million in Q2 2026; TTM through Jun 2026 was $315.6 million, a 3.28% decrease from a year earlier, with the FY2025 full-year figure at $327.6 million, up 2.26% from the prior year.
  • Inventory Average was $315.6 million for Q2 2026 at Emergent BioSolutions, down from $335.5 million in the prior quarter.
  • The five-year high for Inventory Average was $476.8 million in Q3 2022, with the low at $312.8 million in Q1 2025.
  • Average Inventory Average over 5 years is $355.5 million, with a median of $344.5 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Inventory Average grew 26.99% in 2022, then declined 25.72% in 2023.
  • Over 5 years, Inventory Average stood at $439.4 million in 2022, then decreased by 22.29% to $341.5 million in 2023, then fell by 7.12% to $317.2 million in 2024, then advanced by 10.29% to $349.8 million in 2025, then dropped by 9.79% to $315.6 million in 2026.
  • The last three Inventory Average figures came in at $315.6 million (Q2 2026), $335.5 million (Q1 2026), and $349.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 14.86 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 5.09 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 6.34 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 6.25 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 10.31 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 2.75 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 707.10 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 315.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 315.60 Mn
Mar 31, 2026 335.50 Mn
Dec 31, 2025 349.85 Mn
Sep 30, 2025 347.45 Mn
Jun 30, 2025 326.30 Mn
Mar 31, 2025 312.85 Mn
Dec 31, 2024 317.20 Mn
Sep 30, 2024 320.10 Mn
Jun 30, 2024 325.45 Mn
Mar 31, 2024 331.15 Mn
Dec 31, 2023 341.50 Mn
Sep 30, 2023 354.20 Mn
Jun 30, 2023 361.10 Mn
Mar 31, 2023 359.30 Mn
Dec 31, 2022 439.45 Mn
Sep 30, 2022 476.85 Mn
Jun 30, 2022 413.10 Mn
Mar 31, 2022 372.60 Mn
Dec 31, 2021 354.55 Mn
Sep 30, 2021 375.50 Mn
API Access

Emergent BioSolutions Inventory Average API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=inventory-average&ticker=EBS&period=max&api_key=YOUR_API_KEY